Overview

Long-term Study of Cariprazine in Patients With Schizophrenia

Status:
Completed
Trial end date:
2013-01-31
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the long-term safety, tolerability, and pharmacokinetics of cariprazine in patients with schizophrenia.
Phase:
Phase 3
Details
Lead Sponsor:
Forest Laboratories
Collaborator:
Gedeon Richter Ltd.
Treatments:
Cariprazine